FAMAR Group: Dr. Riku Rautsola Appointed New CEO
Kostas is widely recognized for his customer-centric approach, deep knowledge of our industry, and his solution-oriented mindset. During his tenure, he played a pivotal role in successfully guiding the company through multiple ownership transitions, improving operations and customer service and setting a vision for future growth.
At the same time, FAMAR Group is pleased to announce the appointment of Dr.
Under Riku's leadership, FAMAR remains committed to serve its global customers, expand production capacity, accelerate its development partnerships, and invest in its people. Riku will also continue to serve as a member of the Board of Directors.
Kostas will support Riku and the Board of Directors in a senior advisory capacity, focusing on strategic customer relationships and customer engagement.
"We thank
About Famar Group
FAMAR is a leading European provider of pharmaceutical and cosmetic manufacturing and development services. With a legacy of 75 years, FAMAR delivers high-quality dosage forms, including sterile liquids, solids, and semi-solids, creating value for its clients. Operating in
View original content:https://www.prnewswire.com/news-releases/famar-group-dr-riku-rautsola-appointed-new-ceo-302569965.html
SOURCE FAMAR Group
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Share buybacks in Ericsson during the period August 17 - August 21, 2026
- Share buyback programme – week 34
- European Commission Approves DAYBU® (trofinetide) as the First and Only Treatment for Neurobehavioral Symptoms of Rett Syndrome in the European Union
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share